{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:21:16Z","timestamp":1793748076937,"version":"4.6.1"},"reference-count":33,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0514_abs_011\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Congenital generalised lipodystrophies (CGL) are a group of rare genetic disorders characterised by absence of adipose tissue and disturbances in lipid and carbohydrate metabolism. These disorders are characterised by distinct muscular phenotype with acromegaloid features, acanthosis nigricans and hepatomegaly. Metabolic disturbances lead to long-term complications such as diabetes, metabolic fatty liver disease, pancreatitis and cardiovascular disease. To highlight the clinical features and diagnostic approach towards lipodystrophies through the presentation of three Indian children with classical phenotypic and biochemical features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0514_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Three Indian children (two siblings and one unrelated child), all born to non-consanguineous parents with uneventful perinatal histories, presented with progressive abdominal distension and developmental delay. Clinical examination showed generalised loss of subcutaneous fat, muscular habitus, acanthosis nigricans, and hepatosplenomegaly. Laboratory investigations revealed elevated transaminases and hypertriglyceridaemia. Ultrasonography showed hepatomegaly with fatty liver changes. Exome sequencing confirmed presence of variants consistent with the diagnosis of CGL. Though metreleptin was not available, diet modification and increased physical activity were initiated along with lipid lowering drugs which have helped to improve the dyslipidaemia in the siblings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0514_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CGL is a rare but distinct disorder that should be considered in children presenting with generalised muscularity, hepatomegaly, and metabolic abnormalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0514","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:55:49Z","timestamp":1769759749000},"page":"406-413","source":"Crossref","is-referenced-by-count":1,"title":["Berardinelli\u2013Seip congenital lipodystrophy type-2: a case series of three Indian children"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5653-2834","authenticated-orcid":false,"given":"Surbhi","family":"Gyani","sequence":"first","affiliation":[{"name":"Department of Paediatrics , 2075299 Chacha Nehru Bal Chikitsalaya , New Delhi , India"},{"name":"Department of Paediatrics , Pacific Medical College and Hospital , Udaipur , Rajasthan , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithila Das","family":"Mazumder","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , Vydehi Institute of Medical Sciences , Bengaluru , Karanataka , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0414-1698","authenticated-orcid":false,"given":"Medha","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , 2075299 Chacha Nehru Bal Chikitsalaya , New Delhi , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Dokania","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , Vydehi Institute of Medical Sciences , Bengaluru , Karanataka , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , 2075299 Chacha Nehru Bal Chikitsalaya , New Delhi , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Bindhu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , Vydehi Institute of Medical Sciences , Bengaluru , Karanataka , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , 2075299 Chacha Nehru Bal Chikitsalaya , New Delhi , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026080613594064663_j_jpem-2025-0514_ref_001","doi-asserted-by":"crossref","unstructured":"Berardinelli, W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J\u00a0Clin Endocrinol Metab 1954;14:193\u2013204. https:\/\/doi.org\/10.1210\/jcem-14-2-193.","DOI":"10.1210\/jcem-14-2-193"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_002","doi-asserted-by":"crossref","unstructured":"Seip, M, Trygstad, O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr 1996;l413:2\u201328. https:\/\/doi.org\/10.1111\/j.1651-2227.1996.tb14262.x.","DOI":"10.1111\/j.1651-2227.1996.tb14262.x"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_003","doi-asserted-by":"crossref","unstructured":"Garg, A, Wilson, R, Barnes, R, Arioglu, E, Zaidi, Z, Gurakan, F, et al.. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J\u00a0Clin Endocrinol Metab 1999;84:3390\u20134. https:\/\/doi.org\/10.1210\/jcem.84.9.6103.","DOI":"10.1210\/jcem.84.9.6103"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_004","doi-asserted-by":"crossref","unstructured":"Magr\u00e9, J, Del\u00e9pine, M, Khallouf, E, Gedde-Dahl, TJr, Van Maldergem, L, Sobel, E, et al.. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001;28:365\u201370.","DOI":"10.1038\/ng585"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_005","doi-asserted-by":"crossref","unstructured":"Garg, A. Acquired and inherited lipodystrophies. N\u00a0Engl J Med 2004;350:1220\u201334. https:\/\/doi.org\/10.1056\/nejmra025261.","DOI":"10.1056\/NEJMra025261"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_006","doi-asserted-by":"crossref","unstructured":"Richards, S, Aziz, N, Bale, S, Bick, D, Das, S, Gastier-Foster, J, et al.. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","DOI":"10.1038\/gim.2015.30"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_007","doi-asserted-by":"crossref","unstructured":"Brown, RJ, Araujo-Vilar, D, Cheung, PT, Dunger, D, Garg, A, Jack, M, et al.. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J\u00a0Clin Endocrinol Metab 2016;101:4500\u201311. https:\/\/doi.org\/10.1210\/jc.2016-2466.","DOI":"10.1210\/jc.2016-2466"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_008","doi-asserted-by":"crossref","unstructured":"Agarwal, AK, Simha, V, Oral, EA, Moran, SA, Gorden, P, O\u2019Rahilly, S, et al.. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J\u00a0Clin Endocrinol Metab 2003;88:4840\u20137. https:\/\/doi.org\/10.1210\/jc.2003-030855.","DOI":"10.1210\/jc.2003-030855"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_009","doi-asserted-by":"crossref","unstructured":"Lima, JG, Nobrega, LH, de Lima, NN, do Nascimento Santos, MG, Baracho, MF, Jeronimo, SM. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetol Metab Syndr 2016;8:23. https:\/\/doi.org\/10.1186\/s13098-016-0140-x.","DOI":"10.1186\/s13098-016-0140-x"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_010","doi-asserted-by":"crossref","unstructured":"Haque, WA, Shimomura, I, Matsuzawa, Y, Garg, A. Serum adiponectin and leptin levels in patients with lipodystrophies. J\u00a0Clin Endocrinol Metab 2002;87:2395. https:\/\/doi.org\/10.1210\/jcem.87.5.8624.","DOI":"10.1210\/jcem.87.5.8624"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_011","doi-asserted-by":"crossref","unstructured":"Garg, A. Lipodystrophies: genetic and acquired body fat disorders. J\u00a0Clin Endocrinol Metab 2011;6:3313\u201325. https:\/\/doi.org\/10.1210\/jc.2011-1159.","DOI":"10.1210\/jc.2011-1159"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_012","doi-asserted-by":"crossref","unstructured":"Ren, M, Shi, J, Jia, J, Guo, Y, Ni, X, Shi, T. Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction. Orphanet J Rare Dis 2020;15:108. https:\/\/doi.org\/10.1186\/s13023-020-01383-y.","DOI":"10.1186\/s13023-020-01383-y"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_013","doi-asserted-by":"crossref","unstructured":"Van Maldergem, L, Magre, J, Khallouf, TE, Gedde-Dahl, TJr, Delepine, M, Trygstad, O, et al.. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J\u00a0Med Genet 2002;39:722\u201333. https:\/\/doi.org\/10.1136\/jmg.39.10.722.","DOI":"10.1136\/jmg.39.10.722"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_014","doi-asserted-by":"crossref","unstructured":"Javor, ED, Moran, SA, Young, JR, Cochran, EK, DePaoli, AM, Oral, EA, et al.. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J\u00a0Clin Endocrinol Metab 2004;89:3199\u2013207. https:\/\/doi.org\/10.1210\/jc.2003-032140.","DOI":"10.1210\/jc.2003-032140"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_015","doi-asserted-by":"crossref","unstructured":"Bhayana, S, Siu, V, Joubert, G, Clarson, C, Cao, H, Hegele, R. Cardiomyopathy in congenital complete lipodystrophy. Clin Genet 2002;61:283\u20137. https:\/\/doi.org\/10.1034\/j.1399-0004.2002.610407.x.","DOI":"10.1034\/j.1399-0004.2002.610407.x"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_016","doi-asserted-by":"crossref","unstructured":"Akinci, B, Onay, H, Demir, T, Ozen, S, Kayserili, H, Akinci, G, et al.. Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey. J\u00a0Clin Endocrinol Metab 2016;101:2759\u201367. https:\/\/doi.org\/10.1210\/jc.2016-1005.","DOI":"10.1210\/jc.2016-1005"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_017","doi-asserted-by":"crossref","unstructured":"Patni, N, Garg, A. Congenital generalized lipodystrophies - new insights into metabolic dysfunction. Nat Rev Endocrinol 2015;11:522\u201334. https:\/\/doi.org\/10.1038\/nrendo.2015.123.","DOI":"10.1038\/nrendo.2015.123"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_018","doi-asserted-by":"crossref","unstructured":"Garg, A, Fleckenstein, J, Peshock, R, Grundy, S. Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J\u00a0Clin Endocrinol Metab 1992;75:358\u201361. https:\/\/doi.org\/10.1210\/jcem.75.2.1639935.","DOI":"10.1210\/jcem.75.2.1639935"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_019","doi-asserted-by":"crossref","unstructured":"Nolis, T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J\u00a0Hum Genet 2014;59:16\u201323. https:\/\/doi.org\/10.1038\/jhg.2013.107.","DOI":"10.1038\/jhg.2013.107"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_020","unstructured":"Van Maldergem, L. Berardinelli-Siep congenital lipodystrophy. In: Adam, MP, Feldman, J, Mirzaa, GM, Pagon, RA, Wallace, SE, Amemiya, A, editors. GeneReviews(\u00ae). Seattle, WA: University of Washington, Seattle; 1993."},{"key":"2026080613594064663_j_jpem-2025-0514_ref_021","doi-asserted-by":"crossref","unstructured":"Dyment, DA, Gibson, WT, Huang, L, Bassyouni, H, Hegele, RA, Innes, AM. Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome. Eur J Med Genet 2014;57:524\u20136. https:\/\/doi.org\/10.1016\/j.ejmg.2014.06.006.","DOI":"10.1016\/j.ejmg.2014.06.006"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_022","doi-asserted-by":"crossref","unstructured":"Huang, HH, Chen, TH, Hsiao, HP, Huang, CT, Wang, CC, Shiau, YH, et al.. A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene. Kaohsiung J Med Sci 2010;26:615\u201320. https:\/\/doi.org\/10.1016\/s1607-551x(10)70094-2.","DOI":"10.1016\/S1607-551X(10)70094-2"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_023","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Iglesias, S, Crocker, M, O\u2019Callaghan, M, Darling, A, Garc\u00eda-Cazorla, A, Domingo-Jim\u00e9nez, R, et al.. Celia\u2019s encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant. Neurogenetics 2019;20:73\u201382.","DOI":"10.1007\/s10048-019-00574-5"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_024","doi-asserted-by":"crossref","unstructured":"Wang, Y, Guo, J, Zhang, PQ, Liu, F, Li, H. Case report: a case of progressive encephalopathy with or without lipodystrophy caused by BSCL2 variant and literature review. Front Genet 2025;16:1528563. https:\/\/doi.org\/10.3389\/fgene.2025.1528563.","DOI":"10.3389\/fgene.2025.1528563"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_025","doi-asserted-by":"crossref","unstructured":"Schwarz, JM, Cooper, DN, Schuelke, M, Seelow, D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014;11:361\u20132. https:\/\/doi.org\/10.1038\/nmeth.2890.","DOI":"10.1038\/nmeth.2890"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_026","doi-asserted-by":"crossref","unstructured":"Sherry, ST, Ward, M, Sirotkin, K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 1999;9:677\u20139. https:\/\/doi.org\/10.1101\/gr.9.8.677.","DOI":"10.1101\/gr.9.8.677"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_027","doi-asserted-by":"crossref","unstructured":"Karczewski, KJ, Francioli, LC, Tiao, G, Cummings, BB, Alf\u00f6ldi, J, Wang, Q, et al.. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","DOI":"10.1530\/ey.17.14.3"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_028","doi-asserted-by":"crossref","unstructured":"Rahman, OU, Khawar, N, Khan, MA, Ahmed, J, Khattak, K, Al-Aama, JY, et al.. Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family. Diagn Pathol 2013;8:78. https:\/\/doi.org\/10.1186\/1746-1596-8-78.","DOI":"10.1186\/1746-1596-8-78"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_029","doi-asserted-by":"crossref","unstructured":"Landrum, MJ, Lee, JM, Riley, GR, Jang, W, Rubinstein, WS, Church, DM, et al.. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014;42:D980\u20135. https:\/\/doi.org\/10.1093\/nar\/gkt1113.","DOI":"10.1093\/nar\/gkt1113"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_030","doi-asserted-by":"crossref","unstructured":"Foss-Freitas, MC, Akinci, B, Luo, Y, Stratton, A, Oral, EA. Diagnostic strategies and clinical management of lipodystrophy. Expet Rev Endocrinol Metab 2020;15:95\u2013114. https:\/\/doi.org\/10.1080\/17446651.2020.1735360.","DOI":"10.1080\/17446651.2020.1735360"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_031","doi-asserted-by":"crossref","unstructured":"Oral, EA, Chan, JL. Rationale for leptin-replacement therapy for severe lipodystrophy. Endocr Pract 2010;16:324\u201333. https:\/\/doi.org\/10.4158\/ep09155.ra.","DOI":"10.4158\/EP09155.RA"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_032","doi-asserted-by":"crossref","unstructured":"Brown, RJ, Oral, EA, Cochran, E, Ara\u00fajo-Vilar, D, Savage, DB, Long, A, et al.. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine 2018;60:479\u201389. https:\/\/doi.org\/10.1007\/s12020-018-1589-1.","DOI":"10.1007\/s12020-018-1589-1"},{"key":"2026080613594064663_j_jpem-2025-0514_ref_033","doi-asserted-by":"crossref","unstructured":"Mayerson, AB, Hundal, RS, Dufour, S, Lebon, V, Befroy, D, Cline, GW, et al.. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 2002;51:797\u2013802. https:\/\/doi.org\/10.2337\/diabetes.51.3.797.","DOI":"10.2337\/diabetes.51.3.797"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0514\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0514\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:01:04Z","timestamp":1786024864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0514\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,17]]},"published-print":{"date-parts":[[2026,4,24]]}},"alternative-id":["10.1515\/jpem-2025-0514"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0514","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}